THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Takeda and Halozyme expand global collaboration on vedolizumab delivery technology

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Takeda announced a global collaboration and license agreement with Halozyme granting Takeda exclusive access to Halozyme’s ENHANZE drug-delivery technology for use with vedolizumab, marketed as ENTYVIO.

Current status
Official collaboration
Known availability
The published source describes the collaboration; timing details remain under review.
Place
Osaka, Japan
Source checked
September 17, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.